Ladenburg Thalmann & Co. analyst Michael Higgins maintained a Buy rating on BiomX (PHGE - Research Report) today and set a price target of $6.00. The company's shares opened today at $0.84.Higgins covers the Healthcare sector, focusing on stocks such as Artelo Biosciences, BiomX, and Astria Therapeutics. According to TipRanks, Higgins has an average return of 5.3% and a 30.41% success rate on recommended stocks. Currently, the analyst consensus on BiomX is a Strong Buy with an average price target of $7.33, which is a 772.62% upside from current levels. In a report released today, H.C. Wainwright also maintained a Buy rating on the stock with a $10.00 price target.
https://www.tipranks.com/news/blurbs/ladenburg-thalmann-co-sticks-to-its-buy-rating-for-biomx-phge?utm_source=advfn.com&utm_medium=referral
BiomX (AMEX:PHGE)
Graphique Historique de l'Action
De Jan 2023 à Fév 2023 Plus de graphiques de la Bourse BiomX
BiomX (AMEX:PHGE)
Graphique Historique de l'Action
De Fév 2022 à Fév 2023 Plus de graphiques de la Bourse BiomX